Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Debt to Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Debt to Equity for 2 consecutive years, with $0.26 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $0.26 in Q4 2025 year-over-year; TTM through Oct 2025 was $0.26, a N/A change, with the full-year FY2025 number at $0.2, up 198.49% from a year prior.
  • Debt to Equity was $0.26 for Q4 2025 at Kestra Medical Technologies, up from $0.23 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.71 in Q1 2025 to a low of -$0.2 in Q2 2024.